| Cerebrovascular Accident |
1 |
1 |
| Thromboembolism |
0 |
0.64 |
| Plasma |
0 |
0.6 |
| Proteomics |
0 |
0.52 |
| Depression |
0 |
0.99 |
| Major Depression |
0 |
0.41 |
| Artificial Intelligence |
0 |
0.22 |
| Blood |
0 |
0.22 |
| Brain |
0 |
0.22 |
| Involuntary Emotional Expression Disorder |
0 |
0.22 |
| California |
0 |
0.15 |
| Neuroinflammation |
0 |
0.15 |
| Psychosocial |
0 |
0.15 |
| Cognitive Impairment |
0 |
0.11 |
| Traumatic Brain Injury |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Multiple Sclerosis |
0 |
0.08 |
| Biomarker |
0 |
0.07 |
| Cognition |
0 |
0.07 |
| Cytokines |
0 |
0.07 |
| Fellowship |
0 |
0.07 |
| Impairment |
0 |
0.07 |
| Injury |
0 |
0.07 |
| Interleukin |
0 |
0.07 |
| Ischemic Stroke |
0 |
0.07 |
| Maryland |
0 |
0.07 |
| Mood Disorders |
0 |
0.07 |
| Neurosurgery |
0 |
0.07 |
| Psychology |
0 |
0.07 |
| Scar |
0 |
0.07 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.07 |
| Somatic |
0 |
0.07 |
| Stress |
0 |
0.07 |
| UK Site Content |
0 |
0.07 |